It is well known that physical activity has a beneficial effect on health by lowering the risk for non-communicable diseases, such as cardiovascular diseases, diabetes, certain forms of cancer and symptoms of depression.
The physiological effects of physical exercise on such different conditions imply that muscles can communicate with distant organs, and it has been shown that muscle cells secrete signaling particles called extracellular vesicles (EVs).
EVs are derived from cellular membranes and are packed with biologically active cargo including nucleic acids, proteins, and lipids that reflect the state of the host cell. Secreted by cells into extracellular space, EVs have the unique ability to communicate with other cells, neighbouring or distant, altering the recipient cell’s phenotype.
Little is known about EVs released from skeletal muscles during exercise and how they communicate both with neighbouring muscle cells and with other cell types located at distant sites.
This project aims to provide new knowledge about EVs released from skeletal muscles during exercise. Both the cargo of EVs and how they communicate with other cells will be studied.
The project is highly relevant to society as the burden of non-communicable diseases is increasing. The search for exercise factors that can contribute to the development of an “exercise pill” that provides the beneficial effects of exercise and possibly reverses the negative burden of non-communicable diseases is highly desired.
Research questions and methodology
The primary objective of the project is to explore how skeletal muscle communicates the effects of exercise through extracellular vesicles.
We have recently shown that electrical pulse stimulation (EPS - an in vitro model of physical activity) changes the EV cargo significantly. Proteomic and transcriptomic analysis revealed several interesting changes in both protein and microRNA content after EPS.
We found changes in appetite regulating factors, implying a role for physical activity in improving appetite regulation.
We will further characterize EVs derived from exercising muscle, to evaluate the metabolite content and whether these muscle-derived EVs can communicate the beneficial effects of exercise to target cells, such as insulin-resistant muscle cells and hepatocytes.
Skeletal muscle cells, isolated from human biopsies, will be grown, stimulated with different EPS protocols, and EVs will be isolated from the cell culture media. The total metabolite content of EVs will be analysed by metabolomics.
Further, EVs from EPS treated muscle cells will be added to insulin resistant muscle cells and cultured hepatocytes to see whether insulin sensitivity and energy metabolism can be improved.